The use of biochip cardiac array technology for early diagnosis of acute coronary syndromes

Journal of Medical Biochemistry

Volumn 28, Issue 4, 2009, Pages 293-299

  Sypniewska, Grazyna ^a   Sawicki, Marcin ^a   Krintus, Magdalena ^a   Kozinski, Marek ^a   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Acute coronary syndromes; Cardiac biomarkers; H FABP; Troponin

Indexed keywords

CARBONATE DEHYDRATASE III; MYOGLOBIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BIOCHIP; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HOSPITAL ADMISSION; HUMAN; MALE; UNSTABLE ANGINA PECTORIS;

ANGINA;

EID: 70449368524     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-009-0025-8     Document Type: Article

References (12)

1. Apple FS, Smith SW, Pearce LA, Murakami MAM. Assessment of the multiple biomarker approach for diagnosis of myocardial infarction in patients presen - ting with symptoms suggestive of acute coronary synd - ro me. Clin Chem 2009; 55: 93-100.
2. Vuori J, Syrjala H, Vaananen H. Myoglobin: Carbonic Anhydrase III ratio: Highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. Clin Chem 1996; 42: 107-109 (Pubitemid 26030393)
3. Vuotikka P, Ylitalo K, Vuori J, Väänänen K, Kaukoranta P, Lepojärvi M, et al. Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery. Scand Cardiovasc J 2003; 37: 23-29 (Pubitemid 36609028)
4. Glatz JF, Van Der Vusse GJ. Cellular fatty acid binding proteins. Their function and physiological significance. Prog Lipid Res 1996; 35: 243-282
5. Aslan D, Sandberg S. Simple statistics in diagnostic tests. Journal of Medical Biochemistry 2006, 26: 309-313
6. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asa - yama K, Kiura H, et al. Human heart-type cytoplasmic fatty acid binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of HFABP in comparison with myoglobin and CK-MB. Clin Chem Lab Med 2000; 38: 231-238
7. Ishii J, Ozaki Y, Lu J, Kitagawa F, Kuno T, Nakano T, et al. Prognostic value of serum concentration of heart-type fatty acid binding protein relative to cardiac troponin T on admission in the early hours of acute coronary synd - rome. Clin Chem 2005; 51: 1397-1404
8. O'Donoghue M, De Lemos JA, Morrow DA, Murphy SA, Buros J, Cannon C, et al. Prognostic utility of HFABP in patients with acute coronary syndromes. Circu - lation 2006; 114: 550-557
9. Zaninotto M, Mion MM, Novello E, Altinier S, Rocco S, Cacciavillani L, et al. Analytical evaluation of new hearttype fatty acid binding protein automated assay. Clin Chem Lab Med 2006; 44: 1383-1385
10. Zaninotto M, Mion MM, Novello E, Altinier S, Plebani M. New biochemical markers: From bench to bedside. Clin Chim Acta 2007; 381: 14-20.
11. Valle HA, Riesgo LG, Bel MS, Gonzalo FE, Sanchez MS, Oliva LI. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008; 15: 140-144
12. Sawicki M, Odrowaz-Sypniewska G, Krintus M, Ostrow - ska-Nowak J, Pilaczynska-Cemel M, Budzbon D, et al. Evaluation of efficacy of heart-type fatty acid binding protein (H-FABP) for diagnosis of acute coronary syndro mes. Diagn Lab 2008; 44: 459-65..